🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Oral vs Intravenous Dexamethasone in Total Knee Arthroplasty

Recruitingn/aAges 50 Years - 80 YearsAllHaseki Training and Research Hospital
NCT07442812 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective observational cohort study aims to evaluate the association between perioperative dexamethasone administration and early postoperative recovery following primary total knee arthroplasty. In routine clinical practice, dexamethasone may be administered orally, intravenously, or not administered, depending on the surgeon's established perioperative protocol. The primary objective is to assess early postoperative recovery in terms of pain intensity, functional mobility, and knee joint range of motion. Secondary objectives include evaluation of inflammatory response, postoperative metabolic changes, opioid requirement, and the severity of postoperative nausea and vomiting (PONV). Group allocation is non-randomized and determined solely by the standard perioperative management approach routinely applied by the surgeon selected by the patient. No additional interventions are

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 50 and 80 years * Diagnosis of primary knee osteoarthritis (primary gonarthrosis) * Scheduled for elective primary total knee arthroplasty * ASA physical status I or II * Ability to ambulate independently (with or without assistive devices) preoperatively * Ability to understand study procedures and complete pain and functional assessments * Provision of written informed consent Exclusion Criteria: * Revision total knee arthroplasty * History of knee joint infection * Inflammatory arthritis (e.g., rheumatoid arthritis) * Chronic systemic corticosteroid use * Uncontrolled diabetes mellitus * Known endocrine disorders affecting glucose metabolism * Active infection at any site * Known hypersensitivity to corticosteroids * Severe hepatic, renal, or cardiac disease * Neurological or musculoskeletal disorders affecting gait or balance * Inability or unwillingness to comply with study procedures
💊

What it tests

  • Routine perioperative management
📍

Where

1 site
Sultangazi Haseki Training and Research Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy